viernes, 19 de agosto de 2016

Zika diagnostic update | New cross-species immune system reference (open access!)

New FDA Logo Blue

August 18, 2016  |  FDA Medical Countermeasures Initiative Update

Emergency Use Authorization banner

Zika Diagnostic EUA

First commercial serological test available under EUA
On August 17, 2016, FDA issued (PDF, 528 KB) an Emergency Use Authorization (EUA) for emergency use of InBios International, Inc.’s ZIKV Detect™ IgM Capture ELISA for the presumptive detection of Zika virus IgM antibodies in human sera. This is the first commercially available serological test for Zika available under EUA (the first serological test, the CDC Zika MAC-ELISA, was initially authorized for use in February 2016). 
An EUA is a tool FDA can use to allow the use of certain medical products for emergencies based on scientific data. Including the ZIKV Detect™ IgM Capture ELISA, FDA has issued 9EUAs for Zika diagnostic tests, as of August 18, 2016.

Related information

CyTOF mass cytometer (Credit: Stanford)

Cross-Species Immune System Reference

In an MCMi Regulatory Science project, Stanford University researchers used mass cytometry to conduct the first single-cell comprehensive cross-species analyses of immune system function. The resulting data, including analysis tools to evaluate results, are now available to the research community through a free, open-accesswebsite.


In case you missed it

More MCMi news & events

No hay comentarios: